
Two Wall Street firms raised Micron price targets, with Citi moving to $840 and Mizuho to $800, implying further upside from the current $706 share price. Mizuho cited continued strong NAND and DRAM pricing into 2027, supported by insatiable demand for high-bandwidth memory, eSSD, and potential HBF supply tightening, plus possible Samsung strike-related supply disruption. The article also points to very strong earnings expectations ahead of Micron's June 24 report, with revenue seen up 261% to $33.6 billion and EPS up 10x to $19.02.
The market is starting to price Micron less like a cyclical memory supplier and more like a constrained capacity provider in an AI-driven scarcity regime. The key second-order effect is that stronger DRAM/NAND pricing doesn’t just lift near-term margins; it extends the window where capital discipline can remain intact, which mechanically delays the usual supply response that eventually kills the cycle. If pricing really holds into 2027, the earnings power re-rate is larger than consensus appears to assume because the market is still mentally anchored to a one-year upcycle, not a multi-year structural shortage. The bigger setup is that the most obvious competitor risk may actually be a supply-side shock, not demand fade. Any disruption at Samsung would be disproportionately bullish for the whole memory stack because it removes the marginal price-setter just as enterprise storage and HBM demand are still ramping; that can create a faster-than-expected spot-to-contract price passthrough. The hidden beneficiary is NVDA indirectly: tighter memory conditions can worsen delivery timelines and BOM costs, but as long as AI capex budgets remain elastic, suppliers with the best allocation power should defend margins better than downstream buyers can compress them. The main risk is that the market may be extrapolating an AI supercycle into 2027 without sufficient consideration of end-demand digestion. Once cloud customers normalize inventories, the weakest link is usually NAND first, then DRAM; that sequence would hit MU’s multiple before the revenue line visibly rolls over. Another underappreciated risk is that elevated pricing itself can accelerate substitution, lower utilization in adjacent devices, and entice capacity additions from less-disciplined peers, which would matter more in 12-18 months than over the next two quarters. Consensus appears to be underweight the duration of this cycle, but potentially overweight the certainty of it. The correct trade here is not blind long-only exposure; it is owning MU through earnings and into the next pricing prints while protecting against a summer/fall fade. The asymmetry is favorable over the next 1-2 quarters, but the setup becomes materially less attractive if the street starts embedding 2027 pricing in valuation without evidence that supply remains capped.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment